Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75%
gel. This study is designed to evaluate the safety and efficacy of this formulation in
subjects with Acne Vulgaris